Hannu Rajaniemi is a sci-fi author and biotech entrepreneur. Perhaps most famously known for his 2010 release, The Quantum Thief. Away from writing, Rajaniemi is the co-founder of Helix Nanotechnologies, a startup building the world's most advanced mRNA platform to create a unified interface to the immune system.

DALL. · E 3 is an AI tool that generates images based on prompts.

Rajaniemi is drawn to the newly developing range of biotechnology possibilities that, for him, is clearly going to redefine what being human is within the next century. On a five-year timescale, Rajaniemi would be excited if we could demonstrate closing the loop with the immune system: reading information from the immune system, and then writing something back to help it deal with whatever has popped up. An example here would be a 100,000-patient cancer prevention trial, where it can be demonstrated that we can prevent patients with early-stage cancer from getting advanced tumurs. For him, that would be a strong signal that we're on track for some sort of full-spectrum immune-computer interface.

‍